Session E: Hepatitis C treatment, care and support
Tracks
.
Wednesday, February 19, 2020 |
4:15 PM - 5:30 PM |
Central 2 & 3 |
Speaker
Professor Mark Sonderup
Associate Professor
UCT
Direct acting antivirals: a revolution in cure
4:15 PM - 4:30 PMBiography
Mark Sonderup with an MBChB from the University of Cape Town in 1995. Following his internship training, his postgraduate training was at the University of Cape Town and Groote Schuur Hospital where he obtained a Fellowship of the College of Physicians in 2002. Between 2002 and 2004, he completed a 2 year fellowship in Hepatology at the UCT/MRC Liver Research Centre and Liver Clinic at Groote Schuur Hospital. He briefly worked in the UK before being appointed as a Senior Specialist in the Department of Medicine and Division of Hepatology at UCT and Groote Schuur Hospital in 2007. He was granted a FRCP (London) in 2018. He is currently Associate Professor in the Department of Medicine and Division of Hepatology. Research interest include viral hepatitis and drug induced liver injuries. He assisted in co-authoring the national viral hepatitis guidelines and elimination strategy for South Africa. He currently serves on the WHO Strategic Advisory Committee on Viral Hepatitis.
Professor Wendy Spearman
Professor
University of Cape Town
Integrated HIV, TB and viral hepatitis services for people who use drugs
4:30 PM - 4:45 PMBiography
Wendy Spearman is Head of the Division of Hepatology, Department of Medicine, Faculty of Health Sciences at the University of Cape Town. Together with Mark Sonderup, is co-lead of the ‘Viral Hepatitis in sub-Saharan Africa” ECHO Clinic program and is lead clinical consultant on the National Guidelines on the management and prevention of viral hepatitis in South Africa.
Professor Gregory Dore
Head, Viral Hepatitis Clinical Research Program
Kirby Institute, UNSW
DAA treatment outcomes and reinfection among people who inject drugs
4:45 PM - 5:00 PMBiography
Scientia Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years.
Panel
Questions & Discussion
5:00 PM - 5:30 PMBiography
Chair
Angela McBride
Executive Director
SANPUD
Mfezi Mcingana
KP Program Director
TB HIV Care
